๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Taiyen Biotech Co., Ltd. (TPE:1737)
Taiwan flag Taiwan ยท Delayed Price ยท Currency is TWD
29.25
-0.35 (-1.18%)
Nov 20, 2026, 1:30 PM CST

Taiyen Biotech Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3,2003,3083,2383,4093,6144,096
Revenue Growth
-2.24%2.15%-5.01%-5.67%-11.77%30.84%
Gross Profit
1,2321,3411,3211,2571,2771,373
Operating Income
416.34474.19354.54321.44445.05529.18
Net Income
376.76399.87371.52300.39426.7393.23
Earnings Per Share
1.881.991.851.502.131.96
EPS Growth
13.30%7.57%23.33%-29.58%8.67%7.69%

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Salt Products and Packaged Water
2,6702,6082,6362,4822,370
Other Department
104.6884.3180.7366.1561.88
Biotechnology Cleaning and Maintenance Department
470.07470.57474.59515.91432.37
Engineering and Labor Department
88.5994.47319.25570.361,254
Adjustments and Eliminations
-25.46-18.75-102.24-20.64-23.32
Total
3,3083,2383,4093,6144,096

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,7481,7461,9381,8401,8822,080
Total Debt
106.8125.52205.2220.17135.44391.98
Net Cash (Debt)
1,6411,6201,7331,6191,7471,688
Net Cash Growth
6.54%-6.49%7.00%-7.29%3.46%0.42%
Net Cash Per Share
8.208.078.648.088.718.42

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
566.96432.05660.12454.54580.69600.08
Capital Expenditures
-235.46-300.16-307.61-341.65-246.11-388.79
Free Cash Flow
331.5131.89352.51112.89334.58211.29
Free Cash Flow Growth
19.32%-62.59%212.26%-66.26%58.35%183.28%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
38.48%40.54%40.79%36.89%35.33%33.53%
Operating Margin
13.01%14.34%10.95%9.43%12.32%12.92%
Pretax Margin
14.37%14.93%13.37%9.65%14.68%12.45%
Profit Margin
11.77%12.09%11.47%8.81%11.81%9.60%
FCF Margin
10.36%3.99%10.89%3.31%9.26%5.16%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
1.4001.4001.3001.2001.5001.500
Dividend Per Share Growth
7.69%7.69%8.33%-20.00%0%11.11%
Dividend Yield
4.79%4.42%4.01%3.51%4.62%4.52%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
15.5515.8617.4722.7715.2116.89
Forward PE
-15.5215.5215.5215.5215.52
P/FCF Ratio
17.6548.0718.4160.5919.4031.43
PS Ratio
1.831.922.002.011.801.62